A Phase II Prospective,...

A Phase II Prospective, Randomized, Double‐Blind , Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor–Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting

Sánchez‐Rovira, Pedro, Hirschberg, Angelica Lindén, Gil‐Gil, Miguel, Bermejo‐De Las Heras, Begoña, Nieto‐Magro, Concepción
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2020-0417
Date:
May, 2020
File:
PDF, 702 KB
2020
Conversion to is in progress
Conversion to is failed